Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
They also suggest that 0.20 mg per kg weight could be the adequate starting dose, although these data should be confirmed in prospective studies in which steroid dose is adjusted to body weight.
This was associated with general malaise. Treatment with montelukast and salmeterol was stopped and high dose oral prednisolone was commenced together with appropriate analgesia. The patient was also ...
A therapy tradition has existed for decades to administer methyl-prednisolone 1000-mg intravenously daily for 3 consecutive days (followed by high-dose oral treatment). The rationale for this ...
Baxter International Inc. , a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five ...
Since their first use for treating rheumatoid arthritis (RA) in the late 1940s, glucocorticoids (GCs) have been representing a substantial part of the therapeutic arsenal for RA. However, even if GCs ...
HMGoG has today launched a public awareness campaign highlighting the dangers of cocaine use. The festive season sees an increase in cocaine use at social events and the campaign aims to inform the ...
AstraZeneca and Merck , known as MSD outside of the United States and Canada, today announced long-term results from the OlympiA Phase 3 trial which showed LYNPARZA (olaparib) demonstrated sustained, ...
1 Division of Molecular and Genetic Medicine, Royal Hallamshire Hospital, Sheffield, UK 2 Gastroenterology and Liver Unit, Royal Hallamshire Hospital, Sheffield, UK 3 Gastroenterology Unit, John ...
LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial ...
Ali Gayward, easyJet's UK Country Manager, said: “We are delighted that Gibraltar is the latest destination to join our ...